Search
Displaying 31–40 of 1001 results
-
4DMT Planning Phase 3 Clinical Trial for Wet AMD Gene Therapy
Research NewsKnown as 4D-150, the wet AMD gene therapy performed well in a Phase 2b clinical trial.
-
Expert panelists will highlight the barriers that block blind and visually impaired people from engaging with your business and discuss how partnering with organizations like the Foundation Fighting Blindness can provide practical solutions to enhance your bottom line.
-
Eye on the Cure Podcast | Episode 73: Dr. Zuhal Butuner
Eye on the CureDr. Zuhal Butuner talks about her company’s two emerging RNA therapies for LCA10 and USH2A.
-
AAVantgarde Bio’s Dual-Vector USH1B Gene Therapy Moves into Phase 1/2 Clinical Trial
Research NewsThe trial is the first ever for a dual AAV gene therapy delivered to the retina.
-
Foundation News
Innovative Ways to Support Research for Treatments and Cures for Blinding Diseases
-
Research News
The Phase 3 trial is expected to begin in Q1 2025
-
Foundation Fighting Blindness Hosts Chicago Night for Sight Event
Foundation NewsThe October 5th event will raise awareness and fund research driving treatments and cures for blinding diseases and macular degeneration.
-
Recording Available: Foundation Insights Forum – August 29, 2024
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on August 29, 2024.
-
Perseverance of a Six-Time Paralympian
Beacon StoriesAs a six-time goalball Paralympian, Lisa has turned her progressive vision loss into a powerful source of strength and inspiration. Through her incredible journey—overcoming barriers, achieving five Paralympic medals, and becoming a passionate disabilities advocate—Lisa exemplifies how embracing life’s challenges can lead to extraordinary success and personal growth.
-
Think of donor-advised funds like a savings account for the sole purpose of charitable giving. Individuals, families, or groups contribute to their donor-advised fund that is managed by a sponsoring organization, such as a community foundation or financial institution.
